Data gathered: April 15
AI Stock Analysis - Teva Pharmaceutical (TEVA)
Analysis generated May 4, 2024. Powered by Chat GPT.
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that specializes in generic and specialty medicines, with a focus on neurological, respiratory, oncology, and autoimmune diseases among other therapeutic areas. Headquartered in Israel, Teva is one of the largest generic drug manufacturers in the world and has a complex portfolio of products and a strong pipeline of generic and specialty medications. The company is operating in a highly competitive and regulated market but has built a reputation for producing affordable and high-quality drugs.
Stock Alerts - Teva Pharmaceutical (TEVA)
 |
Teva Pharmaceutical | April 10 Price is down by -5.7% in the last 24h. |
|
Teva Pharmaceutical | April 9 Price is down by -5.5% in the last 24h. |
|
Teva Pharmaceutical | April 7 Over the past few months, there has been a noticeable downward trend in Job postings. |
|
Teva Pharmaceutical | April 4 Price is down by -5.3% in the last 24h. |
Alternative Data for Teva Pharmaceutical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 384 | Sign up | Sign up | Sign up |
| Sentiment | 72 | Sign up | Sign up | Sign up |
| Webpage traffic | 101,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 18 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 73 | Sign up | Sign up | Sign up |
| Facebook Followers | 54,856 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 60 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 26,551 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,697 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 8,380 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 61 | Sign up | Sign up | Sign up |
| Linkedin Employees | 29,754 | Sign up | Sign up | Sign up |
About Teva Pharmaceutical
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
| Price | $13.60 |
| Target Price | Sign up |
| Volume | 9,360,000 |
| Market Cap | $15.4B |
| Year Range | $12.82 - $22.77 |
| Dividend Yield | 0% |
| PE Ratio | 30.17 |
| Analyst Rating | 86% buy |
| Earnings Date | May 7 '25 |
| Industry | Drug Manufacturers |
In the news
 |
Wellington Management Group LLP Has $4.10 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)April 12 - ETF Daily News |
|
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Purchased by Orion Portfolio Solutions LLCApril 10 - ETF Daily News |
 |
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case TheoryApril 8 - Yahoo Entertainment |
|
Zacks Research Has Positive Outlook for TEVA FY2025 EarningsApril 6 - ETF Daily News |
|
Teva Pharmaceutical Industries (NYSE:TEVA) Raised to “Buy” at StockNews.comApril 5 - ETF Daily News |
|
What is Zacks Research’s Estimate for TEVA Q2 Earnings?April 5 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 4.33B | 4.1B | 2.15B | -437M | 208M | 0.690 |
| Q2 '24 | 4.16B | 3.89B | 2.02B | -846M | 254M | 0.610 |
| Q1 '24 | 3.82B | 3.9B | 1.77B | -139M | 54M | 0.480 |
| Q4 '23 | 3.48B | 3.84B | 2.42B | 429M | 988M | 1.000 |
| Q3 '23 | 3.85B | 3.2B | 1.85B | 69M | 638M | 0.600 |
Insider Transactions View All
| Francis Richard D filed to sell 271,783 shares at $15.9. March 6 '25 |
| McAvoy David R. filed to sell 11,914 shares at $15.9. March 6 '25 |
| Fox Christine filed to sell 58,384 shares at $15.9. March 6 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$154.36 0% | 50 |
 |
Eli Lilly and CompanyLLY |
$754.35 0% | 69 |
 |
PfizerPFE |
$22.12 0% | 32 |
 |
AstrazenecaAZN |
$68.01 0% | 42 |
 |
AbbVieABBV |
$179.1 0% | 35 |
Read more about Teva Pharmaceutical (TEVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Teva Pharmaceutical?
The Market Cap of Teva Pharmaceutical is $15.4B.
What is Teva Pharmaceutical's PE Ratio?
As of today, Teva Pharmaceutical's PE (Price to Earnings) ratio is 30.17.
When does Teva Pharmaceutical report earnings?
Teva Pharmaceutical will report its next earnings on May 7 '25.
What is the current stock price of Teva Pharmaceutical?
Currently, the price of one share of Teva Pharmaceutical stock is $13.60.
How can I analyze the TEVA stock price chart for investment decisions?
The TEVA stock price chart above provides a comprehensive visual representation of Teva Pharmaceutical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Teva Pharmaceutical shares. Our platform offers an up-to-date TEVA stock price chart, along with technical data analysis and alternative data insights.
Does TEVA offer dividends to its shareholders?
As of our latest update, Teva Pharmaceutical (TEVA) does not offer dividends to its shareholders. Investors interested in Teva Pharmaceutical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Teva Pharmaceutical?
Some of the similar stocks of Teva Pharmaceutical are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.